MeSH Term | Global publications | Solely African publications | African + global collaborations | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
HIV Infections | 55,609 | 80.82 | 2431 | 85.48 | 10,876 | 90.91 |
HIV-1 | 19,945 | 28.99 | 378 | 13.29 | 2284 | 19.09 |
Anti-HIV Agents | 12,114 | 17.61 | 434 | 15.26 | 2647 | 22.12 |
Risk Factors | 7494 | 10.89 | 390 | 13.71 | 1525 | 12.75 |
Viral Load | 6839 | 9.94 | 159 | 5.59 | 1290 | 10.78 |
Antiretroviral Therapy, Highly Active | 6758 | 9.82 | 327 | 11.50 | 1293 | 10.81 |
CD4 Lymphocyte Count | 6296 | 9.15 | 296 | 10.41 | 1604 | 13.41 |
Prevalence | 6172 | 8.97 | 463 | 16.28 | 1643 | 13.73 |
Treatment Outcome | 5074 | 7.37 | 200 | 7.03 | 1091 | 9.12 |
Sexual Behavior | 4636 | 6.74 | 179 | 6.29 | 949 | 7.93 |
Anti-Retroviral Agents | 4529 | 6.58 | 196 | 6.89 | 1266 | 10.58 |
Surveys and Questionnaires | 4137 | 6.01 | 313 | 11.01 | 859 | 7.18 |
Acquired Immunodeficiency Syndrome | 4047 | 5.88 | 253 | 8.90 | 524 | 4.38 |
Homosexuality, Male | 3986 | 5.79 | 22 | 0.77 | 239 | 2.00 |
HIV | 3802 | 5.53 | 138 | 4.85 | 537 | 4.49 |
Pregnancy | 3728 | 5.42 | 287 | 10.09 | 1557 | 13.01 |
HIV Seropositivity | 3604 | 5.24 | 241 | 8.47 | 787 | 6.58 |
RNA, Viral | 3497 | 5.08 | 48 | 1.69 | 467 | 3.90 |
Health Knowledge, Attitudes, Practice | 3468 | 5.04 | 268 | 9.42 | 761 | 6.36 |
Risk-Taking | 3418 | 4.97 | 90 | 3.16 | 505 | 4.22 |
United States | 3332 | 4.84 | 9 | 0.32 | 159 | 1.33 |
Coinfection | 3238 | 4.71 | 204 | 7.17 | 673 | 5.63 |
South Africa | 3197 | 4.65 | 832 | 29.25 | 2179 | 18.21 |
CD4-Positive T-Lymphocytes | 3186 | 4.63 | 63 | 2.22 | 356 | 2.98 |
Sexual Partners | 3042 | 4.42 | 103 | 3.62 | 725 | 6.06 |
Socioeconomic Factors | 2872 | 4.17 | 191 | 6.72 | 664 | 5.55 |
Incidence | 2758 | 4.01 | 113 | 3.97 | 723 | 6.04 |
Drug Resistance, Viral | 2750 | 4.00 | 42 | 1.48 | 500 | 4.18 |
Virus Replication | 2693 | 3.91 | 17 | 0.60 | 105 | 0.88 |
Time Factors | 2615 | 3.80 | 93 | 3.27 | 566 | 4.73 |
Genotype | 2577 | 3.75 | 64 | 2.25 | 473 | 3.95 |